These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 24508995)

  • 21. The human IL-17A/F heterodimer: a two-faced cytokine with unique receptor recognition properties.
    Goepfert A; Lehmann S; Wirth E; Rondeau JM
    Sci Rep; 2017 Aug; 7(1):8906. PubMed ID: 28827714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Staphylococcal-associated molecular patterns enhance expression of immune defense genes induced by IL-17 in mammary epithelial cells.
    Bougarn S; Cunha P; Gilbert FB; Harmache A; Foucras G; Rainard P
    Cytokine; 2011 Dec; 56(3):749-59. PubMed ID: 22004923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional specialization of interleukin-17 family members.
    Iwakura Y; Ishigame H; Saijo S; Nakae S
    Immunity; 2011 Feb; 34(2):149-62. PubMed ID: 21349428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.
    Hu Y; Ota N; Peng I; Refino CJ; Danilenko DM; Caplazi P; Ouyang W
    J Immunol; 2010 Apr; 184(8):4307-16. PubMed ID: 20231694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The IL-17 pathway as a major therapeutic target in autoimmune diseases.
    Hu Y; Shen F; Crellin NK; Ouyang W
    Ann N Y Acad Sci; 2011 Jan; 1217():60-76. PubMed ID: 21155836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IL-17-induced dimerization of IL-17RA drives the formation of the IL-17 signalosome to potentiate signaling.
    Goepfert A; Barske C; Lehmann S; Wirth E; Willemsen J; Gudjonsson JE; Ward NL; Sarkar MK; Hemmig R; Kolbinger F; Rondeau JM
    Cell Rep; 2022 Oct; 41(3):111489. PubMed ID: 36260993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compressive force stimulates the gene expression of IL-17s and their receptors in MC3T3-E1 cells.
    Zhang F; Wang CL; Koyama Y; Mitsui N; Shionome C; Sanuki R; Suzuki N; Mayahara K; Shimizu N; Maeno M
    Connect Tissue Res; 2010 Oct; 51(5):359-69. PubMed ID: 20497006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.
    Onishi RM; Park SJ; Hanel W; Ho AW; Maitra A; Gaffen SL
    J Biol Chem; 2010 Oct; 285(43):32751-32759. PubMed ID: 20729198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood.
    Zrioual S; Toh ML; Tournadre A; Zhou Y; Cazalis MA; Pachot A; Miossec V; Miossec P
    J Immunol; 2008 Jan; 180(1):655-63. PubMed ID: 18097068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice.
    Danzaki K; Matsui Y; Ikesue M; Ohta D; Ito K; Kanayama M; Kurotaki D; Morimoto J; Iwakura Y; Yagita H; Tsutsui H; Uede T
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):273-80. PubMed ID: 22116098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IL-17R activation of human periodontal ligament fibroblasts induces IL-23 p19 production: Differential involvement of NF-κB versus JNK/AP-1 pathways.
    Zhu L; Wu Y; Wei H; Xing X; Zhan N; Xiong H; Peng B
    Mol Immunol; 2011 Jan; 48(4):647-56. PubMed ID: 21145111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Directed evolution of a soluble human IL-17A receptor for the inhibition of psoriasis plaque formation in a mouse model.
    Zaretsky M; Etzyoni R; Kaye J; Sklair-Tavron L; Aharoni A
    Chem Biol; 2013 Feb; 20(2):202-11. PubMed ID: 23438749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression and Potential Regulatory Role of IL-17F in Pathogenesis of Chronic Periodontitis.
    Luo Z; Wang H; Chen J; Kang J; Sun Z; Wu Y
    Inflammation; 2015; 38(3):978-86. PubMed ID: 25384562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin-17A activation on bronchial epithelium and basophils: a novel inflammatory mechanism.
    Wong CK; Cao J; Yin YB; Lam CW
    Eur Respir J; 2010 Apr; 35(4):883-93. PubMed ID: 19741026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-17/Th17 targeting: on the road to prevent chronic destructive arthritis?
    Lubberts E
    Cytokine; 2008 Feb; 41(2):84-91. PubMed ID: 18039580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-17 induces AP-1 activity and cellular transformation via upregulation of tumor progression locus 2 activity.
    Kim G; Khanal P; Lim SC; Yun HJ; Ahn SG; Ki SH; Choi HS
    Carcinogenesis; 2013 Feb; 34(2):341-50. PubMed ID: 23125217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brief Report: Arthritis in KRN T Cell Receptor-Transgenic Mice Does Not Require Interleukin-17 or Th17 Cells.
    Auger JL; Cowan HM; Engelson BJ; Kashem SW; Prinz I; Binstadt BA
    Arthritis Rheumatol; 2016 Aug; 68(8):1849-55. PubMed ID: 26882006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure and signalling in the IL-17 receptor family.
    Gaffen SL
    Nat Rev Immunol; 2009 Aug; 9(8):556-67. PubMed ID: 19575028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cutting edge: interleukin 17 signals through a heteromeric receptor complex.
    Toy D; Kugler D; Wolfson M; Vanden Bos T; Gurgel J; Derry J; Tocker J; Peschon J
    J Immunol; 2006 Jul; 177(1):36-9. PubMed ID: 16785495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Th17 pathway in recent-onset autoimmune diabetes.
    Fores JP; Crisostomo LG; Orii NM; Santos AS; Fukui RT; Matioli SR; de Moraes Vasconcelos D; Silva MERD
    Cell Immunol; 2018 Feb; 324():8-13. PubMed ID: 29183760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.